Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders

Article ID	Journal	Published Year	Pages	File Type
8275391	Journal of the Neurological Sciences	2015	6 Pages	PDF

Abstract

These findings suggest that D-ER may be a potential treatment for gait impairments, beyond walking speed and dexterity in pwMS. Further investigation regarding D-ER response is warranted.

Keywords

EDSS FDA BBT MSWS-12 PwMS 9HPT TWR 4-AP Timed 25-Foot Walk T25FW 4-aminopyridine CNS Dalfampridine gait Food and Drug Administration central nervous system Dexterity Expanded Disability Status Scale Multiple sclerosis Potassium Walking

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Ageing

Preview

Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders

Authors

A.C. Lo, J.A. Ruiz, C.M. Koenig, B.M. Anderson, K.M. Olson, E.W. Triche,